New vaccine against hand, foot, and mouth disease
Part of Infections clinical trials.
This trial tests a new vaccine that protects against two common causes of hand, foot, and mouth disease, a viral illness that mostly affects young children. It may help prevent this uncomfortable and sometimes serious infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 months and 59 years old.
- If you are a woman of childbearing age, you must agree to use birth control for 12 months.
- You must not have had a vaccine against enterovirus 71 or a history of hand, foot, and mouth disease.
- You must be in good health overall, with no serious long-term conditions like heart, kidney, or immune system problems.
- You must not have a history of severe allergic reactions to vaccines.
- You must not have taken certain medications (like steroids or immune-suppressing drugs) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This study tests a vaccine to protect against hand, foot, and mouth disease (HFMD) caused by four common viruses. It is for healthy children aged 6 to 71 months, and aims to see if the vaccine is safe and effective.
This study tests an experimental vaccine against hand, foot, and mouth disease in healthy children aged 6 to 71 months. The vaccine aims to protect against the EV71 virus, a common cause of this illness.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This trial tests whether breathing in a medication called pegylated interferon helps children with mild hand, foot, and mouth disease recover faster. It is for children ages 1 to 6 who have had symptoms like fever or rash for 3 days or less.
This study simply watches children with hand, foot, and mouth disease or herpangina to learn more about these illnesses. Your child's regular care won't change, and no extra treatments are given.
Hear when a new Hand, Foot and Mouth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.